← Full peptide calculator

Free tool

Survodutide Dosage Calculator: mg to U-100 Units for an Investigational Dual Agonist

Survodutide Dosage Calculator: mg to U-100 Units for an Investigational Dual Agonist

To convert a survodutide dose to units, first find your concentration: divide the vial’s milligrams by the milliliters of bacteriostatic water you add. A 10 mg vial in 1 mL gives 10 mg/mL. On a U-100 syringe every 0.01 mL reads as 1 unit, so units = dose in mg ÷ concentration × 100 — and, as a strength check, every 0.1 mL (10 units) of that 10 mg/mL solution holds 1 mg. Survodutide is investigational with no established dose, so enter your own protocol value; the tool only does the arithmetic. This is arithmetic only, not medical advice; verify with a licensed clinician.

Survodutide reconstitution & dosage calculator X

Reconstitution / draw volume / syringe units / supply-chain

Arithmetic + reference toolNot medical advice
Inputs
Research context
Product form
Target dose
Weight unit
Syringe barrel
Draw to
50units
0.5 mL5 mg/mL2.5 mg / dose
1 mL syringe - 100 u/mLFits
50 u050100 u
ARITHMETIC OK - VERIFY CLINICALLY

Arithmetic checks out. Confirm clinically, against the label, and against the actual vial before any use.

10 mg
4
0 mg
28 days
-
-

Independent check - dose mg / concentration mg/mL = volume. U-100 units = mL x 100.

Reference context
Research context
Survodutide
StatusInvestigational; no FDA/UK/EU marketing approvalRouteSubcutaneousFrequencyOnce weekly

Phase 2 dose-finding tested 0.6, 2.4, 3.6 and 4.8 mg weekly with 20-week escalation

Published range0.6-4.8 mg

Study range only; no approved commercial concentration or label.

Trial escalation was controlled; the published range is not a personal titration schedule.

PubMed - PMID 38330987
Finnrick supply-chain
Apr 2025 - May 2026
6.8/10
Avg quality score
7 vendors - 27 samples tested
98.39-99.95%
+/- 20 %
10 mg

Supply-chain signal only - not a potency guarantee. Enter the COA's tested mg and purity above so the math reflects the real vial.

View on finnrick.com
Reconstitution planner

Reverse: pick a dose and the units you want it to read, then calculate diluent to add.

Reverse
Desired dose
1 mL
10 mg/mL
4
Blend planner

Same-syringe co-draw. Reconstitute each peptide in its own vial, then draw them into one syringe.

Co-draw
2.5 mg/mLDraw 4 u · 0.04 mL
2.5 mg/mLDraw 4 u · 0.04 mL
Combined draw
Fits 1 mL8 u0.08 mL
  • Reconstitute each peptide in its own vial — never add water to multiple peptides in one vial.
  • Only co-draw peptides with the same diluent (e.g. both bacteriostatic water) and compatible pH.
  • Draw and inject fresh — do not pre-mix and store; mixture stability is not established.
  • No blended stack is clinically validated. Verify each component and confirm with a clinician.
Formula and source context only. Not medical advice; verify with a clinician, product label, pharmacist, or approved research protocol. Do not use this tool to infer sterility, potency, purity, stability, compatibility, or an appropriate dose. Catalog and supply-chain data: finnrick.com/products - research date 2026-06-24.

Survodutide dose to syringe units: reference chart

Survodutide - U-100 syringe units by vial size, water volume and dose
Vial + waterConcentrationUnits per 1 mg0.6 mg2.4 mg3.6 mg4.8 mg
10 mg + 1 mL10 mg/mL106243648
10 mg + 2 mL5 mg/mL2012487296
10 mg + 3 mL3.33 mg/mL301872108144

Concentration = vial strength divided by the bacteriostatic water added. On a U-100 syringe 100 units = 1 mL, so units = (dose divided by concentration) x 100. Values are syringe units, not milligrams. Amber values exceed 100 units, which is more than one standard 1 mL U-100 syringe holds, so that combination needs a more concentrated solution. Columns are the doses studied in the published trial - they describe what has been studied or labeled, not what anyone should take, and this page gives no dosing advice. Multiply the units-per-1-mg figure by your own dose in milligrams to convert any amount. For vial sizes or doses not shown here, use the general mg to units converter.

Sources

  • PubMed - PMID 38330987Published Phase 2 human RCT. Basis for the regulatory status, route, frequency and published range shown on this page, and for the dose columns in the chart above. Source last checked 2026-06-24

Frequently asked questions

Has any regulatory agency approved survodutide for sale?

No. Survodutide (development code BI 456906, from Boehringer Ingelheim) has no marketing approval in any country and remains an investigational compound in active clinical development. There is no approved label, concentration, or fill volume, so anything you calculate here falls outside an approved use.

Why can’t I reuse a semaglutide dose chart for survodutide?

Survodutide is a dual agonist that activates both the GLP-1 and the glucagon receptor, unlike single-target GLP-1 medicines. Potency and dosing do not transfer between different molecules, and this calculator performs only mg-to-unit arithmetic — it applies no equivalence factor between one drug and another.

Where does the 10 mg default vial amount come from?

Ten milligrams reflects a commonly cited research-vial quantity, not an approved presentation. Because survodutide has no approved concentration, the mg you enter divided by the diluent volume you choose is what defines the strength — the tool simply performs that division. Always read the actual vial in your hand rather than trusting the default.

Does this page tell me how much survodutide to take?

No. It is an arithmetic unit-converter, not medical advice. There is no established or approved self-administration dose for survodutide because it is investigational; the 0.6-4.8 mg weekly figures are study context only, never a recommendation. Confirm anything you plan to do with a licensed clinician.

How was survodutide dosed in its Phase 2 study?

As a once-weekly subcutaneous injection, with the weekly amount raised gradually across a study-controlled 20-week escalation, all under clinical supervision. That staged, monitored design is exactly why entering a single target number into a calculator does not reproduce the trial protocol.